A5056801079- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Pituitary Gland Disorders and Treatments
- Inflammatory Biomarkers in Disease Prognosis
- Healthcare Regulation
- Angiogenesis and VEGF in Cancer
- Neuroendocrine Tumor Research Advances
- Chronic Myeloid Leukemia Treatments
- Neuroblastoma Research and Treatments
- Kruppel-like factors research
- Quality and Safety in Healthcare
- Advanced Breast Cancer Therapies
- Peptidase Inhibition and Analysis
- Ferroptosis and cancer prognosis
Faculdade Metropolitana de Manaus
2023
Centro Universitário do Rio Grande do Norte
2023
Novartis (United States)
2021
Novartis (Switzerland)
2019
Hospital São Lucas da PUCRS
2007
Hospital São Paulo
2007
2056 Background: GBM are the most common primary brain tumors in adults. Despite available treatment they carry a poor prognosis with recurrences patients (pts) after initial therapy. PDGF signaling has been postulated to play role transformation. We have demonstrated that PDGFRβ is expressed tumor cells 50% and peritumoral endothelial 65% of (Barrios et al, abstract 11518, Proc ASCO 2006). Imatinib, an inhibitor PDGFRa/β kinase activity could therapeutic these cases. Methods: evaluated...
Introdução: Á vitamina D é um hormônio esteroide cuja principal função a regulação do metabolismo ósseo. O excesso de capaz ocasionar toxicidade ao organismo, causando hipercalcemia, hipercalciúria, hiperfosfatemia e resultando em fraquezas, calcificações tecidos moles, entre outros. Objetivo: Evidenciar os efeitos associados uso excessivo D. Metodologia Trata-se estudo revisão sistemática, Resultados: Foram selecionados 12 artigos para compor responder objetivos estabelecidos neste...